StockData
GoodRx Holdings, Inc. logo

GoodRx Holdings, Inc. (GDRX) stock

GDRXNasdaqServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 11/3039% below fair value
$3.36−0.11 (-3.17%)

Close on Nov 18, 2026Market cap $1.15BP/E 84.0Yield –

GoodRx net income

Net income is the profit left for shareholders after every expense, interest and tax.

GoodRx's net income for the twelve months ending Jun 30, 2026 was $16.25M, down 53.0% year over year. For fiscal 2025 it was $30.44M, up 85.7% from the year before. The highest annual figure on record is $66.05M in fiscal 2019.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.44M+85.7%
FY2024Dec 31, 2024$16.39M–
FY2023Dec 31, 2023-$8.87M–
FY2022Dec 31, 2022-$32.83M–
FY2021Dec 31, 2021-$25.25M–
FY2020Dec 31, 2020-$293.62M-544.6%
FY2019Dec 31, 2019$66.05M+50.8%
FY2018Dec 31, 2018$43.79M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.54M-33.5%
Q1 FY2026Mar 31, 2026$1.17M-89.4%
Q4 FY2025Dec 31, 2025$5.43M-19.5%
Q3 FY2025Sep 30, 2025$1.12M-71.8%
Q2 FY2025Jun 30, 2025$12.84M+91.9%
Q1 FY2025Mar 31, 2025$11.05M–
Q4 FY2024Dec 31, 2024$6.74M–
Q3 FY2024Sep 30, 2024$3.97M–
Q2 FY2024Jun 30, 2024$6.69M-88.6%
Q1 FY2024Mar 31, 2024-$1.01M–
Q4 FY2023Dec 31, 2023-$25.87M–
Q3 FY2023Sep 30, 2023-$38.50M–
Q2 FY2023Jun 30, 2023$58.79M–
Q1 FY2023Mar 31, 2023-$3.29M-126.8%
Q4 FY2022Dec 31, 2022-$1.97M–
Q3 FY2022Sep 30, 2022-$41.73M–
Q2 FY2022Jun 30, 2022-$1.42M-104.6%
Q1 FY2022Mar 31, 2022$12.29M+637.0%
Q4 FY2021Dec 31, 2021-$39.91M–
Q3 FY2021Sep 30, 2021-$18.07M–
Q2 FY2021Jun 30, 2021$31.06M+13.6%
Q1 FY2021Mar 31, 2021$1.67M-93.9%
Q4 FY2020Dec 31, 2020-$298.27M-2058.8%
Q3 FY2020Sep 30, 2020-$50.03M-355.0%
Q2 FY2020Jun 30, 2020$27.34M+39.1%
Q1 FY2020Mar 31, 2020$27.35M+136.7%
Q4 FY2019Dec 31, 2019$15.23M–
Q3 FY2019Sep 30, 2019$19.62M–
Q2 FY2019Jun 30, 2019$19.65M–
Q1 FY2019Mar 31, 2019$11.55M–

More GoodRx figures

See a number that looks wrong?